Pelthos Therapeutics
$24.46
0
-$0.54-2.16% 19:59 Today
Statistics
Day High
25.84
Day Low
24.22
52W High
37.5
52W Low
18.19
Volume
40,888
Avg. Volume
53,344
Mkt Cap
85.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12NovExpected
Q4 0
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-6.62
-4.61
-2.59
-0.58
Expected EPS
-2.901429
Actual EPS
N/A
Financials
-257.93%Profit Margin
Unprofitable16.8MRevenue
-43.32MNet Income
Analyst Ratings
62.00Average Price Target
The highest estimate is 64.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens. The Company currently has three U.S. Food and Drug Administration (FDA) approved products in its commercial portfolio, in various stages of commercialization, including ZELSUVMITM, XEPI, and XEGLYZE. The company operates in two reporting segments: the sale, promotion, and commercialization of approved commercial products, the Commercial Operations segment, and research and development activities related to developing a novel and proprietary class of NaV blockers that target the body's peripheral nervous system; and supportive activities to expand the NITRICIL nitric oxide-based technology.
Show more...
CEO
Scott Plesha
Employees
92
Country
United States
ISIN
US1711262048
Listings
0 Comments
Share your thoughts
FAQ
What is Pelthos Therapeutics stock price today?▼
The current price of PTHS is $24.46 USD — it has decreased by -2.16% in the past 24 hours. Watch Pelthos Therapeutics stock price performance more closely on the chart.
What is Pelthos Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Pelthos Therapeutics stocks are traded under the ticker PTHS.
Is Pelthos Therapeutics stock price growing?▼
PTHS stock has fallen by -4.12% compared to the previous week, the month change is a -11.92% fall, over the last year Pelthos Therapeutics has showed a +6.35% increase.
What is Pelthos Therapeutics market cap?▼
Today Pelthos Therapeutics has the market capitalization of 85.01M
When is the next Pelthos Therapeutics earnings date?▼
Pelthos Therapeutics is going to release the next earnings report on November 12, 2026.
What were Pelthos Therapeutics earnings last quarter?▼
PTHS earnings for the last quarter are -6.62 USD per share, whereas the estimation was -2.82 USD resulting in a -134.87% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pelthos Therapeutics revenue for the last year?▼
Pelthos Therapeutics revenue for the last year amounts to 16.8M USD.
What is Pelthos Therapeutics net income for the last year?▼
PTHS net income for the last year is -43.32M USD.
How many employees does Pelthos Therapeutics have?▼
As of August 28, 2026, the company has 92 employees.
In which sector is Pelthos Therapeutics located?▼
Pelthos Therapeutics operates in the Health & Wellness sector.
When did Pelthos Therapeutics complete a stock split?▼
The last stock split for Pelthos Therapeutics was on July 02, 2025 with a ratio of 1:10.
Where is Pelthos Therapeutics headquartered?▼
Pelthos Therapeutics is headquartered in DURHAM, United States.